Expert Commentary

The beginning of the end of the Pap?

Author and Disclosure Information

 

References

One weakness of the study is that the data were collected from only one health care system and therefore may not be representative of all populations. Additionally, cotesting was performed on 2 separately collected specimens, which may have reduced HPV testing performance.

WHAT THIS EVIDENCE MEANS FOR PRACTICE

Excessive cervical cancer screening, including frequent cotesting, could have minimal cancer prevention benefits while increasing the harms of screening. These data confirm guidance showing HPV testing alone is an effective cervical cancer screening strategy.
-- Mark H. Einstein, MD, MS

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Pages

Recommended Reading

Is mannitol a good alternative agent for evaluating ureteral patency after gynecologic surgery?
MDedge ObGyn
Teens with PID underscreened for HIV, syphilis
MDedge ObGyn
Alopecia tied to nearly fivefold increase in fibroids in African American women
MDedge ObGyn
In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges
MDedge ObGyn
FDA issues safety measures for all gadolinium-based contrast agents for MRI
MDedge ObGyn
Protocols to reduce opioid use and shorten length of stay
MDedge ObGyn
Implementing enhanced recovery protocols for gynecologic surgery
MDedge ObGyn
Greater gynecological but not medical risks with hysteroscopic sterilization
MDedge ObGyn
Practice essentials: Everyday contraception considerations
MDedge ObGyn
Sleep improved with urinary incontinence treatment
MDedge ObGyn